100 Active Studies

Essential Tremor Clinical Trials Near You

Find 100 actively recruiting essential tremor research studies near you. Connect with study sites, check eligibility, and explore new treatment options.

100
Active Trials
308+
Locations
72,987
Participants Needed

Recruiting Studies

RecruitingNCT07064473

A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these conditions and do not have a history of heart failure. ...

10 locations(Anniston, Fairhope, Guntersville)
11,800 participants
Boehringer Ingelheim
View Study Details
RecruitingNCT02915198

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

This research will help us to learn if the medicine called metformin reduces the risk of death, heart attacks, and/or strokes in Veterans who have pre-diabetes and heart or blood vessel problems....

10 locations(Phoenix, Tucson, Little Rock)
7,410 participants
VA Office of Research and Development
View Study Details
RecruitingNCT05390892

PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes

PRECIDENTD is a randomized, open label, pragmatic clinical trial designed to compare rates of the total number of cardiovascular, kidney, and death events among two alternative treatments for patients...

8 locations(Baltimore, Duluth, Columbia)
6,000 participants
Brigham and Women's Hospital
View Study Details
RecruitingNCT03625648

Pentoxifylline in Diabetic Kidney Disease

Pentoxifylline (PTX) is a medication that has been on the market since 1984 for use in disease in the blood vessels of the legs. There is some preliminary information that it may protect the kidneys f...

10 locations(Phoenix, Little Rock, Loma Linda)
2,510 participants
VA Office of Research and Development
View Study Details
RecruitingNCT06980025

Aspirin Dose Escalation for the Prevention of Recurrent Preterm Delivery Trial

This is a phase-III multi-center double-blind randomized clinical trial of 1,800 individuals with a history of prior preterm birth at less than 35 weeks gestation who are randomized to either 162 mg a...

10 locations(Birmingham, San Francisco, Chicago)
1,800 participants
The George Washington University Biostatistics Center
View Study Details
RecruitingNCT06445946

DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes

This is a non-inferiority patient-centered and pragmatic comparative-effectiveness pregnancy randomized controlled trial (RCT) with postpartum maternal and child follow-up through 2 years of 1,572 ind...

10 locations(Tuscaloosa, Los Angeles, San Francisco)
1,572 participants
Ohio State University
View Study Details
RecruitingNCT04068649

Single-Fraction SBRT Versus Standard Palliative Radiation Therapy in Treating Patients With Metastatic Cancer

This phase II trial studies how well single-fraction stereotactic body radiation therapy (SBRT) works when compared to standard radiation therapy in treating patients with cancer that has spread to ot...

3 locations(Buffalo, East Hills, West Islip)
1,500 participants
Roswell Park Cancer Institute
View Study Details
RecruitingNCT04474223

Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)

Fetal complete (i.e., third degree, 3°) atrioventricular block (AVB), identified in the 2nd trimester of pregnancy in an otherwise normally developing heart, is almost universally associated with mate...

10 locations(Phoenix, Los Angeles, Palo Alto)
1,300 participants
NYU Langone Health
View Study Details
RecruitingNCT03678025

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer...

10 locations(Gilbert, Phoenix, Phoenix)
1,273 participants
SWOG Cancer Research Network
View Study Details
RecruitingNCT06952504

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

Researchers are looking for new ways to treat people with proficient mismatch repair (pMMR) endometrial cancer (EC) that is advanced or recurrent. * EC is a type of cancer that starts in the tissues ...

10 locations(Fort Myers, Miami Beach, West Palm Beach)
1,123 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingNCT06628908

Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy

The purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine (SUZ) in participants with pain associated with diabetic peripheral neuropathy (DPN)....

10 locations(Anniston, Birmingham, Daphne)
1,100 participants
Vertex Pharmaceuticals Incorporated
View Study Details
RecruitingNCT07104383

VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)

This is a phase 3, multicenter, 78-week randomized, double-blind, placebo-controlled, parallel arm study that will evaluate the weight loss efficacy as well as safety, tolerability, pharmacodynamic ef...

10 locations(Birmingham, Birmingham, Huntsville)
1,100 participants
Viking Therapeutics, Inc.
View Study Details
RecruitingNCT06061861

Kaiser Permanente Evaluating Nutritional Interventions in Food-Insecure High-Risk Adults Study

The goal of this randomized controlled trial is to compare the effect of receiving 6 months of monetary support for healthy food through a food delivery platform on change in glycosylated hemoglobin (...

2 locations(Pasadena, Pleasanton)
1,100 participants
Kaiser Permanente
View Study Details
RecruitingNCT05535946

ABTECT - Maintenance

This is a multicenter, randomized, placebo-controlled study to evaluate the long-term efficacy and safety of ABX464 50mg and 25mg administered once daily (QD) as maintenance therapy in subjects with m...

10 locations(Birmingham, Dothan, Guntersville)
1,050 participants
Abivax S.A.
View Study Details
RecruitingNCT06957080

A Study of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME

EYE-RES-103 is a randomized, double masked pivotal study to evaluate the efficacy and safety of 2 dose levels of EYE103 in comparison with the active control, ranibizumab, in patients with diabetic ma...

10 locations(Gilbert, Phoenix, Scottsdale)
960 participants
EyeBiotech Ltd.
View Study Details
RecruitingNCT06914895

A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight

The main purpose of this study is to find out how well and how safely tirzepatide works in adults who have type 1 diabetes and obesity or overweight. Participation in the study will last about 49 week...

10 locations(Goleta, Santa Clarita, Aurora)
905 participants
Eli Lilly and Company
View Study Details
RecruitingNCT07076199

A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes

This study compares insulin icodec, an insulin taken once a week to insulin glargine, an insulin taken once a day. The study medicine will be investigated in participants with type 1 diabetes. The stu...

10 locations(Cullman, Concord, Escondido)
877 participants
Novo Nordisk A/S
View Study Details
RecruitingNCT05369052

Safety and Efficacy Study of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults With Moderate or Severe Diabetic Foot Infections (DFI)

This is a Phase 3, multicenter, randomized, double-blind, safety and efficacy study of contezolid acefosamil (IV)/contezolid (PO) compared with linezolid (IV and PO) administered for a total of 14 to ...

10 locations(Corona, Vista, Lom)
865 participants
MicuRx
View Study Details
RecruitingNCT04333576

Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain

Endometriosis is a painful disorder of the uterus affecting 6-10% of women of childbearing age. Endometriosis affects daily activities, social relationships, sexuality and sexual activity, and mental ...

10 locations(Anniston, Birmingham, Birmingham)
800 participants
AbbVie
View Study Details
RecruitingNCT06876649

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

The master protocol study J2N-MC-JZNY provides a framework to enable the evaluation of the long-term safety and efficacy of pirtobrutinib after completion of clinical studies evaluating pirtobrutinib....

10 locations(Miami, Sarasota, Atlanta)
787 participants
Eli Lilly and Company
View Study Details
RecruitingNCT04262466

Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors

Brenetafusp (IMC-F106C) is an immune-mobilizing monoclonal T cell receptor against cancer (ImmTAC ®) designed for the treatment of cancers positive for the tumor-associated antigen PRAME. This is a fi...

10 locations(La Jolla, Los Angeles, Sacramento)
727 participants
Immunocore Ltd
View Study Details
RecruitingNCT07088068

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

This is a multicenter, randomized, double-blind, parallel, placebo-controlled Phase 3, 2-arm study for treatment. The purpose of this study is to measure change in glycemic control and prandial insul...

10 locations(Scottsdale, Huntington Beach, Atlanta)
723 participants
Sanofi
View Study Details
RecruitingNCT06480383

Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder

This is a multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy, safety, and tolerability of ITI-1284 compared with placebo as adjunctive therapy to GAD treatment in ...

10 locations(Chandler, Phoenix, Encino)
705 participants
Intra-Cellular Therapies, Inc.
View Study Details
RecruitingNCT07044336

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

This is a Phase III, 2-arm, randomized, open label, multicenter, global study assessing the efficacy and safety of puxitatug samrotecan compared to physician's choice of chemotherapy (doxorubicin or p...

10 locations(Jupiter, Miami, Miami Beach)
700 participants
AstraZeneca
View Study Details
RecruitingNCT05099770

Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT injections given 3 months (+30 days) apart and delivered percutaneously into biopsied and non-bio...

10 locations(Tucson, Beverly Hills, Glendora)
685 participants
Prokidney
View Study Details
RecruitingNCT04064060

A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials

A Phase 3b, open-label, single-arm, rollover study to evaluate the long-term safety of luspatercept, to the following participants: * Participants receiving luspatercept on a parent protocol at the t...

10 locations(Los Angeles, Oakland, Stanford)
665 participants
Celgene
View Study Details
RecruitingNCT06486441

Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26)

The goal of this clinical study is to find out how the study drug, sacituzumab govitecan (SG) works in participants with endometrial cancer who have received prior treatment with platinum-based chemot...

10 locations(Little Rock, Duarte, La Jolla)
640 participants
Gilead Sciences
View Study Details
RecruitingNCT04108156

A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME

This study will evaluate the efficacy, safety, and Pharmacokinetics (PK) of the PDS with ranibizumab in participants with DME when treated every 24 weeks (Q24W) compared with intravitreal (IVT) ranibi...

10 locations(Mesa, Phoenix, Phoenix)
634 participants
Hoffmann-La Roche
View Study Details
RecruitingNCT04704921

Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD

ABBV-RGX-314 (also known as RGX-314) is being developed as a novel one-time gene therapy for the treatment of neovascular (wet) age-related macular degeneration (wet AMD or nAMD). Wet AMD is character...

10 locations(Phoenix, Sun City, Little Rock)
630 participants
AbbVie
View Study Details
RecruitingNCT06972472

A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes

The main purpose of this study is to see how orforglipron, compared with placebo, helps improve glycemic control in participants with obesity or with overweight and type 2 diabetes. This trial is part...

10 locations(Tucson, San Ramon, Santa Ana)
600 participants
Eli Lilly and Company
View Study Details
RecruitingNCT06989112

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

DESTINY-Endometrial01 will investigate the efficacy of first-line T-DXd + rilvegostomig (Arm A) and/or T-DXd+ pembrolizumab (Arm B) when compared to chemotherapy (carboplatin + paclitaxel) + pembroliz...

10 locations(Tucson, Little Rock, Duarte)
600 participants
AstraZeneca
View Study Details
RecruitingNCT05844982

Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 Mg) Intravitreal Implants Vs Observation for Prevention of VA Loss Due to Radiation Retinopathy

This randomized controlled trial will evaluate the effect of intravitreal faricimab or fluocinolone acetonide (FAc) intravitreal implant compared with observation on long-term visual acuity following ...

10 locations(Palo Alto, Tampa, Chicago)
600 participants
Jaeb Center for Health Research
View Study Details
RecruitingNCT06563895

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

Transthyretin amyloidosis (ATTR) is a disease where the normally occurring transthyretin (TTR) protein falls apart and forms amyloid, a sticky plaque- like substance that accumulates in different orga...

10 locations(La Jolla, Stanford, New Haven)
582 participants
Eidos Therapeutics, a BridgeBio company
View Study Details
RecruitingNCT06701903

Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder

This is a multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy, safety, and tolerability of ITI-1284 as monotherapy treatment in patients meeting Diagnostic and Stati...

10 locations(Little Rock, Culver City, Encino)
570 participants
Intra-Cellular Therapies, Inc.
View Study Details
RecruitingNCT04661358

Fenofibrate for Prevention of DR Worsening

This randomized trial will evaluate the effect of fenofibrate compared with placebo for prevention of diabetic retinopathy (DR) worsening through 6 years of follow-up in eyes with mild to moderately s...

10 locations(Glendale, Huntington Beach, Loma Linda)
560 participants
Jaeb Center for Health Research
View Study Details
RecruitingNCT06850922

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Participants With Diabetic Macular Edema

This study aims to evaluate the ocular and systemic safety, tolerability and efficacy of RO7446603 in participants with diabetic macular edema (DME). The study consists of 2 segments: Phase I (Parts 1...

10 locations(Phoenix, Phoenix, Phoenix)
546 participants
Genentech, Inc.
View Study Details
RecruitingNCT06962280

A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or Overweight

The main purpose of this study is to find out how well and how safely tirzepatide works long-term in adults who have type 1 diabetes and obesity or overweight. Participation in the study will last abo...

10 locations(Bonita, Escondido, Newport Beach)
465 participants
Eli Lilly and Company
View Study Details
RecruitingNCT06542874

A Research Study Comparing How Well Different Doses of the Medicine NNC0487-0111 Lower Blood Sugar in People With Type 2 Diabetes

The study will look at how well different doses of a new medicine called NNC0487-0111 help lower the blood sugar and body weight in people with type 2 diabetes. NNC0487-0111 is a new medicine which ca...

10 locations(Santa Ana, Waterbury, Waterbury)
432 participants
Novo Nordisk A/S
View Study Details
RecruitingNCT05646316

Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer

This phase III trial compares the effect of sentinel lymph node mapping to standard lymph node dissection in reducing the risk of swelling in the legs (lymphedema) in patients undergoing a hysterectom...

10 locations(Washington D.C., Coral Gables, Deerfield Beach)
428 participants
NRG Oncology
View Study Details
RecruitingNCT06033599

Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement

The purpose of this study is to 1) examine barriers and facilitators to implementation of MI and MORE for polysubstance use and evaluate strategies for optimizing training, fidelity, and clinic uptake...

2 locations(New Brunswick, Salt Lake City)
420 participants
Rutgers, The State University of New Jersey
View Study Details
RecruitingNCT06351631

A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)

The primary purpose of the study is to transition participants into an extension study to collect long-term safety and efficacy data. The study will include participants who are safely tolerating bome...

10 locations(Ann Arbor, Durham, Columbus)
400 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingNCT05640999

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

This protocol tests de-escalated adjuvant treatment in patients with POLE-mutated or p53wt/NSMP (p53 wildtype/no specific molecular profile) early-stage endometrial cancer (EC). Patients may be enroll...

10 locations(Anchorage, Tucson, Los Angeles)
393 participants
Canadian Cancer Trials Group
View Study Details
RecruitingNCT06628362

A Study of CT-388 in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus

This is a multi-center, randomized, double-blind, placebo-controlled, parallel group dose-finding study to evaluate the efficacy and safety of CT-388 at low, middle, and high doses in participants who...

10 locations(Anniston, Birmingham, Birmingham)
360 participants
Carmot Therapeutics, Inc.
View Study Details
RecruitingNCT04939090

Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients

This phase III trial compares the effects of olanzapine versus megestrol acetate in treating loss of appetite in patients with cancer that has spread to other places in the body (advanced). Olanzapine...

10 locations(Gilbert, Goodyear, Peoria)
360 participants
Alliance for Clinical Trials in Oncology
View Study Details
RecruitingNCT06233799

Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder

The primary objective of this study is to evaluate the efficacy of extended release naltrexone plus bupropion XL (XR-NTX/BUP-XL) compared to matched injectable and oral placebo (iPLB/oPLB) in reducing...

10 locations(Little Rock, Los Angeles, San Diego)
360 participants
National Institute on Drug Abuse (NIDA)
View Study Details
RecruitingNCT05301413

Social Determinants and a Diabetes Prevention Program Tailored for African Americans

African Americans (AAs) have rates of diabetes mellitus (DM) twice that of Whites and are disproportionately affected by leading risk factors for DM - obesity and low-income. A critical strategy in th...

2 locations(Kansas City, Kansas City)
360 participants
University of Missouri, Kansas City
View Study Details
RecruitingNCT05256225

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

This phase III trial tests whether adding trastuzumab and hyaluronidase-oysk (Herceptin Hylecta \[TM\]) or pertuzumab, trastuzumab and hyaluronidase-zzxf (Phesgo \[TM\]) to the usual chemotherapy (pac...

10 locations(Birmingham, Anchorage, Tucson)
360 participants
National Cancer Institute (NCI)
View Study Details
RecruitingNCT05548296

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

This is an open label Phase 2 study to evaluate the efficacy and safety of ACR-368 as monotherapy or with ultra-low dose gemcitabine (ULDG) sensitization in participants with endometrial cancer....

10 locations(Mobile, Anchorage, Phoenix)
353 participants
Acrivon Therapeutics
View Study Details
RecruitingNCT06893939

Limited Versus Extended Trophic Feeding (LET-FEED) Trial

Study Hypothesis/Question In infants born very preterm, advancing enteral feeds after 24 hours from birth (limited trophic feeds) versus after 72 hours (extended trophic feeds) reduces the risk of all...

6 locations(Birmingham, Tampa, Oklahoma City)
350 participants
University of Washington
View Study Details
RecruitingNCT05215353

A Study Comparing Music Therapy and Cognitive Behavioral Therapy for Anxiety in Cancer Survivors

The researchers are doing this study to compare how music therapy and cognitive behavioral therapy, given virtually, may be able to reduce anxiety in people who have had cancer. In addition, this stud...

3 locations(Miami, New York, Philadelphia)
350 participants
Memorial Sloan Kettering Cancer Center
View Study Details
RecruitingNCT04665206

Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors

This is an open-label, dose escalation and expansion study to evaluate the safety, tolerability, PK, and biological activity of VT3989 administered, alone or in combination, once daily in patients wit...

10 locations(San Francisco, Chicago, Boston)
336 participants
Vivace Therapeutics, Inc
View Study Details
RecruitingNCT06101745

Trial to Visualize the Ureters With Nizaracianine Triflutate in Adults Undergoing Abdominopelvic Surgery

The goal of this clinical trial is to determine if the drug Nizaracianine Triflutate can help surgeons see and avoid the ureters during abdominopelvic surgery. The ureters are thin-wall, collapsible t...

8 locations(Los Angeles, Redwood City, Worcester)
336 participants
Curadel Surgical Innovations, Inc.
View Study Details
RecruitingNCT05018585

A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes

The objective of DIAGNODE-3 is to evaluate the efficacy and safety of three intranodal injections of 4 μg of Diamyd compared to placebo, along with oral Vitamin D supplementation, to preserve endogeno...

10 locations(Newport Beach, Palo Alto, San Diego)
330 participants
Diamyd Medical AB
View Study Details
RecruitingNCT06297603

Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)

The purpose of this study is to investigate the efficacy and safety of retatrutide compared with placebo in participants with Type 2 Diabetes and renal impairment, with inadequate glycemic control on ...

10 locations(Huntsville, Sun City West, Apple Valley)
320 participants
Eli Lilly and Company
View Study Details
RecruitingNCT04787042

Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067

This is a multiphase, multicenter study, which includes a Phase 1a open-label, dose escalation monotherapy study of ST-067 given as an SC injection with or without obinutuzumab \[Gazyva®\] pre-treatme...

6 locations(Scottsdale, Denver, New Haven)
316 participants
Simcha IL-18, Inc.
View Study Details
RecruitingNCT06846320

Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder

Generalized anxiety disorder (GAD) is usually treated with antidepressant therapy (ADT); however, sometimes ADTs alone are not enough to adequately treat GAD. The purpose of this study is to assess ho...

10 locations(Huntsville, Phoenix, Tucson)
315 participants
AbbVie
View Study Details
RecruitingNCT05005975

Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)

To evaluate the long-term safety and tolerability of oral dersimelagon....

10 locations(Huntington Beach, San Francisco, Miami)
301 participants
Mitsubishi Tanabe Pharma America Inc.
View Study Details
RecruitingNCT06619860

Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy

The purpose of this study is to evaluate the efficacy, safety, and tolerability of VX-993 in participants with pain associated with Diabetic Peripheral Neuropathy (DPN)...

10 locations(Cullman, Bakersfield, La Mesa)
300 participants
Vertex Pharmaceuticals Incorporated
View Study Details
RecruitingNCT06962839

A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema

This study is open to adults 18 and older with an eye condition called diabetic macular edema. People are required to have a specific type of diabetic macular edema called centre-involved diabetic mac...

10 locations(Arcadia, Modesto, Pasadena)
300 participants
Boehringer Ingelheim
View Study Details
RecruitingNCT04005378

Disengagement in CSC: Identifying Those at Risk and Addressing Their Needs

Maintaining treatment engagement is critical for first episode psychosis patients to experience gains possible with coordinated specialty care (CSC). This study is designed to identify CSC participant...

3 locations(Lauderdale Lakes, Grand Rapids, Kalamazoo)
300 participants
Northwell Health
View Study Details
RecruitingNCT06375811

Pre-IVF Treatment With a GnRH Antagonist in Women With endometriosis_temp

A Phase 3 clinical trial of oral GnRH antagonist pre-treatment for women with endometriosis who are undergoing IVF, with a primary outcome of live birth rate. The investigators' central hypothesis is ...

5 locations(Aurora, New Haven, Chicago)
297 participants
Yale University
View Study Details
RecruitingNCT06326047

A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Lower Blood Sugar in People With Type 2 Diabetes

This study will look at how well a new medicine called NNC0519-0130 helps people with type 2 diabetes lower their blood sugar and body weight. The study will test up to 7 different doses of NNC0519-01...

10 locations(Chula Vista, Fresno, Fresno)
288 participants
Novo Nordisk A/S
View Study Details
RecruitingNCT06745024

Comparing Radiation Therapy to Usual Care for Patients With High-Risk Bone Asymptomatic Metastases, PREEMPT Trial

This phase III trial compares the effect of adding radiation therapy to usual care on the occurrence of bone-related complications in cancer patients with high-risk bone metastases that are not causin...

10 locations(Fairbanks, Phoenix, Tucson)
280 participants
NRG Oncology
View Study Details
RecruitingNCT05797831

Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

This study evaluates navtemadlin as maintenance treatment for patients with advanced or recurrent endometrial cancer (EC) who have achieved complete response or partial response on chemotherapy. The ...

10 locations(Vallejo, Atlanta, Savannah)
268 participants
Kartos Therapeutics, Inc.
View Study Details
RecruitingNCT05443126

A Study of EP0031 in Patients With Advanced RET-altered Malignancies

The aim of this study is to assess the safety, side effects and effectiveness of EP0031 in patients with advanced RET-altered malignancies (NSCLC)...

10 locations(Los Angeles, Stanford, Washington D.C.)
265 participants
Ellipses Pharma
View Study Details
RecruitingNCT04416269

Oral Anti Diabetic Agents in the Hospital

This randomized controlled clinical trial will assess whether continuation of home oral antidiabetic agents during hospitalization can be used as a safe and effective alternative to insulin therapy in...

3 locations(Atlanta, Atlanta, Atlanta)
260 participants
Emory University
View Study Details
RecruitingNCT06246799

Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes

The primary purpose of this study is to evaluate the efficacy, durability, and mechanism of HbA1c reduction produced by the combination of pioglitazone plus tirzepatide compared to metformin plus sita...

2 locations(San Antonio, San Antonio)
256 participants
The University of Texas Health Science Center at San Antonio
View Study Details
RecruitingNCT06809595

A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)

A Phase 3, Double-blind, Placebo-controlled Study (Part A) with an Open-label Extension (Part B) Evaluating MM120 Compared to Placebo in Generalized Anxiety Disorder - Panorama...

10 locations(Little Rock, Los Angeles, Los Angeles)
250 participants
Mind Medicine, Inc.
View Study Details
RecruitingNCT04031677

Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

This is a multicenter, randomized, open label phase lll trial to assess whether preoperative chemotherapy, as an adjunct to curative-intent surgery, improves the prognosis of high risk DDLPS (dediffer...

10 locations(Phoenix, Duarte, Orange)
250 participants
European Organisation for Research and Treatment of Cancer - EORTC
View Study Details
RecruitingNCT06897475

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

The purpose of this study is to measure the change in hemoglobin A1c (HbA1c) with LY3457263 compared with placebo in participants with type 2 diabetes who are not at HbA1c goal when treated with a sta...

10 locations(Phoenix, Santa Ana, Ocala)
240 participants
Eli Lilly and Company
View Study Details
RecruitingNCT07112872

A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes

This multicenter, randomized, double-blind, placebo- and open-label active comparator-controlled, parallel-group, dose-range-finding, Phase II study aims to evaluate the efficacy, tolerability, and sa...

10 locations(Lake Forest, Rancho Cucamonga, Spring Valley)
240 participants
Hoffmann-La Roche
View Study Details
RecruitingNCT06615557

Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)

This U.S. Phase 3 clinical trial is designed to evaluate the efficacy, safety, and tolerability of the acute intranasal (i.n.) administration of Fasedienol Nasal Spray (fasedienol) (3.2 µg) to relieve...

10 locations(Little Rock, Bellflower, Orange)
236 participants
VistaGen Therapeutics, Inc.
View Study Details
RecruitingNCT06358651

Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-3)

This U.S. Phase 3 clinical trial is designed to evaluate the efficacy, safety, and tolerability of the acute intranasal (i.n.) administration of Fasedienol Nasal Spray (fasedienol) (3.2 µg) to relieve...

10 locations(Phoenix, Fayetteville, Little Rock)
236 participants
VistaGen Therapeutics, Inc.
View Study Details
RecruitingNCT05438212

Comparing the Addition of Radiation Either Before or After Surgery for Patients With Brain Metastases

This phase III trial compares the usual treatment of surgery after stereotactic radiosurgery (SRS) to receiving SRS before surgery in treating patients with cancer that has spread to the brain (brain ...

10 locations(Phoenix, Tucson, Tucson)
236 participants
NRG Oncology
View Study Details
RecruitingNCT05930210

A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer

This Phase 3 study is a randomized, double-blind, vehicle-controlled, multiple-center, parallel study to evaluate efficacy and safety of ENERGI-F703 GEL compared with vehicle control in subjects with ...

10 locations(Miami, Miami, Miami)
230 participants
Energenesis Biomedical Co., Ltd.
View Study Details
RecruitingNCT02710253

Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy

This phase II trial studies the side effects and best dose of radiation therapy and to see how well it works in treating patients with cancer that has spread to other places in the body (metastatic) o...

5 locations(Conroe, Houston, Houston)
230 participants
M.D. Anderson Cancer Center
View Study Details
RecruitingNCT07193563

ENX-102 Phase 2 Social Anxiety Disorder

This is a double-blind study to evaluate the efficacy and safety of ENX-102 in participants with social anxiety disorder (SAD)....

8 locations(Phoenix, Oceanside, Jacksonville)
220 participants
Engrail Therapeutics INC
View Study Details
RecruitingNCT05611931

Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma

The purpose of this study is to evaluate the efficacy and safety of selinexor as a maintenance treatment in patients with p53 wt endometrial carcinoma (EC), who have achieved a partial response (PR) o...

10 locations(Birmingham, Phoenix, Little Rock)
220 participants
Karyopharm Therapeutics Inc
View Study Details
RecruitingNCT06926842

Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)

The main purpose of this study is to investigate efficacy and safety of three doses of petrelintide versus placebo in participants with overweight or obesity and type 2 diabetes....

10 locations(Cullman, Phoenix, Little Rock)
216 participants
Zealand Pharma
View Study Details
RecruitingNCT06257576

Function of Tamsulosin in Older Males Undergoing Surgery with Indwelling Catheter

This study is being done to answer the question: What is the impact of a medication called tamsulosin (also called Flomax) on the rate of postoperative urinary retention (POUR) and catheter-associated...

3 locations(Atlanta, Atlanta, Atlanta)
212 participants
Emory University
View Study Details
RecruitingNCT06840496

To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in Females With Rett Syndrome

Primary Objective • To investigate the efficacy of treatment with oral Bionetide versus placebo in girls and women with Rett syndrome Key Secondary Objective • To investigate the efficacy of treatme...

10 locations(Phoenix, La Jolla, Los Angeles)
210 participants
Biomed Industries, Inc.
View Study Details
RecruitingNCT03550391

Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases

Stereotactic radiosurgery (SRS) is a commonly used treatment for brain tumors. It is a one-day (or in some cases two day), out-patient procedure during which a high dose of radiation is delivered to s...

10 locations(Tucson, Tucson, Corona)
206 participants
Canadian Cancer Trials Group
View Study Details
RecruitingNCT06099769

A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer

The researchers are doing this study to find out if the study drug, enzalutamide, alone or combined with the study drug, mifepristone, is effective in treating advanced or metastatic androgen receptor...

10 locations(Birmingham, San Francisco, Chicago)
201 participants
Memorial Sloan Kettering Cancer Center
View Study Details
RecruitingNCT06741228

A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Voyage)

A Phase 3 Double-blind, Placebo-controlled Study (Part A) with an Open-label Extension (Part B) Evaluating MM120 Compared to Placebo in Generalized Anxiety Disorder - Voyage...

10 locations(Gilbert, La Jolla, San Francisco)
200 participants
Mind Medicine, Inc.
View Study Details
RecruitingNCT05166161

A Long-Term Safety Study of PTC923 in Participants With Phenylketonuria

The main purpose of this study is to evaluate the long-term safety of PTC923 in participants with phenylketonuria, and to evaluate the changes from baseline in dietary phenylalanine (Phe)/protein cons...

10 locations(Aurora, Gainesville, Indianapolis)
200 participants
PTC Therapeutics
View Study Details
RecruitingNCT06111586

FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS)

This is a randomized, parallel group, double-blind Phase 2 study with a 52-week blinded extension evaluating the safety and efficacy of 3 dose levels of frexalimab in comparison with placebo in partic...

10 locations(San Francisco, Denver, Gainesville)
192 participants
Sanofi
View Study Details
RecruitingNCT03422198

Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer

This randomized phase III trial studies short course vaginal cuff brachytherapy to see how well it works compared with standard of care vaginal cuff brachytherapy in treating participants with stage I...

5 locations(Palo Alto, Maywood, Houston)
188 participants
University of Utah
View Study Details
RecruitingNCT05762107

A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes

The goal of this clinical trial is to learn about the effect of the study drug (ZT-01) on low blood sugar (hypoglycemia) in adults with type 1 diabetes (T1D) who have been having low blood sugars ("hy...

10 locations(Escondido, Los Angeles, San Carlos)
186 participants
Zucara Therapeutics Inc.
View Study Details
RecruitingNCT06315751

Efficacy and Safety of Gemlapodect (NOE-105) in Adults and Adolescents With Tourette Syndrome

This study is designed to evaluate the efficacy and safety of gemlapodect (NOE-105) on reducing tics associated with Tourette Syndrome (TS) in adults with TS. Adolescents will be enrolled after a sent...

10 locations(Dothan, Sun City, Bellflower)
180 participants
Noema Pharma AG
View Study Details
RecruitingNCT03675893

RESOLVE: Abemaciclib + Letrozole +/- Metformin, Zotatifin, or Gedatolisib in Endometrial or Low-Grade Serous Ovarian Cancer

This research study is studying a combination of targeted therapies as a possible treatment for estrogen-receptor positive (ER+) endometrial cancer and low-grade serous ovarian cancer. The drugs invo...

3 locations(Boston, Boston, Boston)
180 participants
Dana-Farber Cancer Institute
View Study Details
RecruitingNCT06321302

A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy

This study is open to adults with diabetic retinopathy. People who have non-proliferative diabetic retinopathy of moderate or high severity can join the study. The purpose of this study is to find ou...

10 locations(Phoenix, Bakersfield, Beverly Hills)
178 participants
Boehringer Ingelheim
View Study Details
RecruitingNCT06660394

A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)

This (DEEp SEA Study) is a double-blind, randomized, placebo-controlled, multicenter study to investigate the efficacy, safety, and tolerability of LP352 in the treatment of seizures in children and a...

10 locations(Little Rock, Palo Alto, San Francisco)
160 participants
Longboard Pharmaceuticals
View Study Details
RecruitingNCT05877430

Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer

Study CJB-101-01 will be conducted at multiple centers in the USA and Republic of Korea as an open-label safety and preliminary efficacy study of CJRB-101 in combination with pembrolizumab in subjects...

4 locations(Irvine, Pittsburgh, Seoul)
160 participants
CJ Bioscience, Inc.
View Study Details
RecruitingNCT05267626

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

This is a first in human, open-label, multi-center Phase 1 / 2 study to evaluate the safety, tolerability, and initial efficacy of AU-007 in patients with advanced solid tumors. AU-007 will be adminis...

10 locations(Grand Rapids, Minneapolis, St Louis)
159 participants
Aulos Bioscience, Inc.
View Study Details
RecruitingNCT06042153

DIALYSIS-TIR Study

This study will look at control of blood sugar levels in persons with type 2 diabetes mellitus currently on chronic dialysis. Researchers will compare blood sugar levels in people taking semaglutide t...

5 locations(Chapel Hill, Dallas, Dallas)
157 participants
University of Texas Southwestern Medical Center
View Study Details
RecruitingNCT05351294

Assessment of Early Radiation Oncology Involvement Alongside Standard Oncologic Care in the Managemet

To determine if the experimental approach of early radiation oncology involvement alongside standard oncologic care will result in higher HRQL at 6 months compared to the control arm receiving standar...

6 locations(Jersey City, New Brunswick, New Brunswick)
156 participants
Rutgers, The State University of New Jersey
View Study Details
RecruitingNCT06449677

Bionic Pancreas in CFRD

This multi-center randomized controlled trial (RCT) will compare efficacy and safety endpoints using the insulin-only configuration of the iLet Bionic Pancreas System (BP) versus a control group using...

10 locations(Aurora, New Haven, Atlanta)
150 participants
Jaeb Center for Health Research
View Study Details
RecruitingNCT06334133

Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes

This is a Phase 3 trial of cadisegliatin as adjunctive therapy to insulin in participants with Type 1 Diabetes Mellitus....

10 locations(Escondido, La Jolla, Englewood)
150 participants
vTv Therapeutics
View Study Details
RecruitingNCT06388200

A Phase 3 Study Of OCU400 Gene Therapy for the Treatment Of Retinitis Pigmentosa

This is a Phase 3 study to Assess the Efficacy, Safety and Tolerability of OCU400 in patients with retinitis pigmentosa (RP) associated with RHO mutations and patients with any other RP associated mut...

10 locations(Phoenix, La Jolla, Los Angeles)
150 participants
Ocugen
View Study Details
RecruitingNCT06872125

A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome

The purpose of the study is to evaluate the efficacy, safety, and tolerability of zorevunersen in Patients with Dravet syndrome....

10 locations(Phoenix, Little Rock, Los Angeles)
150 participants
Stoke Therapeutics, Inc
View Study Details

Top Cities for Essential Tremor Clinical Trials

Essential Tremor clinical trials are recruiting across 308 cities. Here are the cities with the most active studies:

About Essential Tremor

Essential tremor is one of the most common movement disorders, causing involuntary shaking, most often in the hands. It is different from Parkinson's disease, though the two can be confused. Treatment includes medications, focused ultrasound, and deep brain stimulation for severe cases.

Clinical trials are advancing new treatments for essential tremor. Currently, 100 studies are recruiting a combined 72,987 participants across the United States. Research is being conducted by 72 organizations including Boehringer Ingelheim, VA Office of Research and Development, Brigham and Women's Hospital and 69 others.

2026 Essential Tremor Research Landscape

As of March 2026, the essential tremor clinical trial landscape includes 100 actively recruiting studies across 308 cities in the United States. These studies are collectively seeking 72,987 participants, with an average enrollment target of 730 per study.

Research is being led by 72 different organizations, including Boehringer Ingelheim, VA Office of Research and Development, Brigham and Women's Hospital, The George Washington University Biostatistics Center, Ohio State University, and 67 others. The large number of sponsors reflects significant research interest and investment in essential tremor treatment advancement.

Geographically, essential tremor trials are most concentrated in Phoenix, Arizona (34 trials); Los Angeles, California (25 trials); Boston, Massachusetts (23 trials); Tucson, Arizona (21 trials); Little Rock, Arkansas (20 trials) and 7 other cities.

Featured Essential Tremor Studies

Highlighted recruiting studies for essential tremor, selected by enrollment size and research scope.

RecruitingNCT07064473

A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these conditions and do not have a history of heart failure. The purpose of this study is to find out if a medicine called vicadrostat, when taken with empagliflozin, helps reduce cardiovascular risk in people with these conditions. The study will compare this ...

Sponsor: Boehringer Ingelheim· 11,800 participants· 10 locations (Anniston, Fairhope, Guntersville, Chandler)
View full study details →
RecruitingNCT02915198

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

This research will help us to learn if the medicine called metformin reduces the risk of death, heart attacks, and/or strokes in Veterans who have pre-diabetes and heart or blood vessel problems.

Sponsor: VA Office of Research and Development· 7,410 participants· 10 locations (Phoenix, Tucson, Little Rock, Loma Linda)
View full study details →
RecruitingNCT05390892

PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes

PRECIDENTD is a randomized, open label, pragmatic clinical trial designed to compare rates of the total number of cardiovascular, kidney, and death events among two alternative treatments for patients with type 2 diabetes (T2D) and either established atherosclerotic cardiovascular disease (ASCVD) or at high risk for ASCVD. To accomplish this objective, we will randomly assign 6,000 patients with e...

Sponsor: Brigham and Women's Hospital· 6,000 participants· 8 locations (Baltimore, Duluth, Columbia, New York)
View full study details →

Frequently Asked Questions About Essential Tremor Clinical Trials

Are there essential tremor clinical trials near me?

Yes, there are 100 essential tremor clinical trials currently recruiting across 308+ cities in the United States, including Phoenix, Arizona; Los Angeles, California; Boston, Massachusetts. Browse the studies above to find one at a location convenient for you.

How do I join a essential tremor clinical trial?

To join a essential tremor clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.

Are essential tremor clinical trials free?

Yes, participation in essential tremor clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.

What types of essential tremor treatments are being studied?

Current essential tremor clinical trials are testing a range of approaches. These include new drugs, combination therapies, medical devices, and other interventions sponsored by 72 research organizations.

Is it safe to participate in essential tremor clinical trials?

Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.

Data updated March 2, 2026 from ClinicalTrials.gov

About This Data

Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.

Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.

Page reviewed by the HelloStudys Research Team · Last updated March 2, 2026 · Data from ClinicalTrials.gov